10-QPeriod: Q2 FY2026

CME GROUP INC. Quarterly Report for Q2 Ended Jun 30, 2026

Filed July 24, 2026For Securities:CME

Summary

CME Group Inc. reported solid financial results for the six months ended June 30, 2026, demonstrating resilience and growth. Total revenues increased by 8% to $3.59 billion, driven by a significant 18% surge in Market Data and Information Services revenue, reaching $462.2 million, and a 6% rise in Clearing and Transaction Fees to $2.90 billion. This revenue growth, coupled with disciplined expense management which saw total expenses increase by 7% to $1.17 billion, resulted in a strong 11% increase in Net Income to $2.20 billion. Diluted Earnings Per Share (EPS) also saw a healthy increase, rising 12% to $6.06. The company's financial position remains robust, supported by strong operating cash flows of $2.21 billion for the six-month period. While cash and cash equivalents decreased from $4.42 billion at the end of 2025 to $2.14 billion at June 30, 2026, this was largely due to significant share repurchases totaling $1.24 billion in the period, alongside substantial dividend payments. The company continues to manage its capital effectively, with a share repurchase program authorization of $1.5 billion remaining, signaling ongoing commitment to returning value to shareholders.

Key Highlights

  • 1Total revenues increased by 8% to $3.59 billion for the six months ended June 30, 2026, compared to the same period in 2025.
  • 2Market Data and Information Services revenue saw a substantial 18% increase, reaching $462.2 million, indicating strong demand for data offerings.
  • 3Clearing and Transaction Fees grew by 6% to $2.90 billion, supported by a 10% increase in overall contract volume.
  • 4Net Income rose by 11% to $2.20 billion, and Diluted Earnings Per Share increased by 12% to $6.06 for the six-month period.
  • 5Operating cash flow remained strong at $2.21 billion for the first six months of 2026.
  • 6The company repurchased $1.24 billion of its Class A common stock and paid significant dividends, demonstrating a commitment to shareholder returns.
  • 7Remaining authorization for share repurchases stands at $1.5 billion, suggesting continued capital return plans.

Frequently Asked Questions

The increase in Market Data and Information Services revenue was driven by higher usage of certain products, increased demand from new customer segments, and price increases for specific products. This segment's growth highlights the continued value and demand for CME Group's data offerings.

The report mentions that heightened geopolitical conflict in the Middle East in early 2026 contributed to increased volatility and uncertainty in various markets, leading to higher contract volumes in areas like equity indexes, energy, and metals as market participants sought to hedge or capitalize on price movements.

CME Group demonstrates a strong commitment to shareholder value through substantial dividend payments and an active share repurchase program. As of June 30, 2026, the company had $1.5 billion remaining under its share repurchase authorization, indicating an ongoing strategy to return capital to shareholders.

Operating expenses increased primarily due to higher license fees (linked to record equity product volumes), increased technology support services (related to the Google Cloud transformation project), higher rent expenses, and increased salaries, benefits, and employer taxes due to salary increases and headcount growth. Marketing expenses also rose due to higher sponsorship, media campaigns, and event costs.